1990-1993 / Barry University Miami, Florida, Master of Science in Nursing, Adult Nurse Practitioner
1984-1988 / Oral Roberts University Tulsa, Oklahoma, Bachelor of Science in Nursing
Work Experience
2008-Present / Adult Nurse Practitioner, Clinical Research Coordinator, Mountain Kidney and Hypertension Associates, PA
2006-2008 / Clinical Research Coordinator, Asheville Gastroenterology Associates, PA
1993-2006 / Adult Nurse Practitioner, Clinical Research Coordinator, Ira L. Lazar, MD, PA
1989-1993 / Director of Nursing, Central Broward Acute Dialysis
1988-1989 / Staff, Charge Nurse, North Ridge Medical Center
Certifications
Adult Nurse Practitioner Certification American Academy of Nurse Practitioners
Certified Clinical Research Coordinator
Research Training
CITI Course in the Protection of Human Subjects, December 2006
CITI Refresher Course, January 2009
Hospital Affiliations
2008-Present / Mission-St. Joseph's Health System
509 Biltmore Avenue
Asheville, NC 28801-4690
Research
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Using XXXX and XXXX in Hyperphosphatemic Chronic Kidney Disease Patients on Hemodialysis
A Phase 3, Randomized, Active-Controlled, Open-Label, Multi-Center Study of the Safety and Efficacy of XXXX Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with XXXX
A Phase 2/3 Multi-Center, Randomized, Placebo-Controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of XXXX Compared with XXXX at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients with HBeAg Positive / Negative Chronic Hepatitis due to Hepatitis B Virus
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of XXXX for 6 Months in Preventing Hepatic Encephalopathy
Assessment of the Efficacy of XXXX on Viral Kinetics, Cytokines, and Innate Immunity in a Group of Insulin Resistant, Treatment Naïve, Chronic Hepatitis C, Genotype 1 Patients
A Randomized, Multi-Center, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of XXXX In Combination with XXXX in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85kg
A Multi-Centered, Prospective, Randomized, Placebo-Controlled Clinical Trial for the Treatment of Significant Steatosis or NASH with XXXX Followed by Treatment of Hepatitis C (HCV) with XXXX
A Study to Describe the Antiviral Effect of XXXX in Blacks/African Americans and Hispanics with Chronic Hepatitis B Virus (HBV) Infection Who are Nucleoside/tide-Naïve
A Phase 3 Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Evaluate the Efficacy of XXXX Vaccination in Adults on Hemodialysis
A Comparison Study of the Safety and Efficacy of XXXX Versus XXXX in Chronic Renal Failure Patients with Anemia
A Phase 4 Prospective, Randomized, Active Center, Double Blind, Double Dummy, Multi-Center Study Comparing the Survival Benefits of XXXX Relative to XXXX.
An Investigational Study to Obtain Clinical Data on the Safety and Efficacy of the XXXX Device in Vascular Access for Hemodialysis Patients
